Chemistry: analytical and immunological testing – Involving production or treatment of antibody
Patent
1981-07-01
1984-10-02
Padgett, Benjamin R.
Chemistry: analytical and immunological testing
Involving production or treatment of antibody
436548, 436804, 436819, 260112R, 424 11, 424 85, 424177, 435 7, 435 29, 435 68, 4351723, 435240, 435948, C12N 1500, G01N 3354, G01N 3360, G01N 3376
Patent
active
044748930
ABSTRACT:
Antibodies having binding affinity for two desired antigens, hereinafter "recombinant monoclonal antibodies"; recombinant monoclonal antibodies produced by a quadroma cell or a trioma cell; and methods for producing recombinant monoclonal antibodies by means of a quadroma cell or a trioma cell, wherein a quadroma cell is the fusion product of a hybridoma cell which produces an antibody having specific binding affinity to one desired antigen and a hybridoma cell which produces an antibody having specific binding affinity for another desired antigen, and wherein a trioma cell is the fusion product of a hybridoma cell which produces an antibody having specific binding affinity to one desired antigen and a lymphocyte which produces an antibody having specific binding affinity to another desired antigen.
REFERENCES:
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4271145 (1981-06-01), Wands et al.
patent: 4284412 (1981-08-01), Hansen et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4349528 (1982-09-01), Koprowski et al.
patent: 4350683 (1982-09-01), Galfre et al.
patent: 4356117 (1982-10-01), Neville et al.
patent: 4359457 (1982-11-01), Neville et al.
patent: 4361544 (1982-11-01), Goldenberg
patent: 4361549 (1982-11-01), Kung et al.
patent: 4361647 (1982-11-01), Remington et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4381292 (1983-04-01), Bieber et al.
patent: 4411993 (1983-10-01), Gillis
De Preval, C. et al., J. Molecular Biology, vol. 102, pp. 657-678, (1976).
Howard, J. C. et al., Immunological Reviews, vol. 47, pp. 139-173 (1979).
Eden, A. et al., J. Immunology, vol. 108 (6), pp. 1605-1608 (1972).
Kohler, G. et al., Nature, vol. 256, pp. 495-497 (1975).
Margulies, D. H. et al., Cell, vol. 8, pp. 405-415 (1976).
Cotton, R. G. H. et al., Nature, vol. 244, pp. 42-43 (7-73).
Schwaber, J. et al., Proc. Natl. Acad. Sciences, vol. 71, No. 6, pp. 2203-2207 (6-1974).
Hammerling, V. et al., J. Experimental Medicine, vol. 128, pp. 1461-1469 (1968).
Raso, V. et al., Federation Proceedings, vol. 37, p. 1350 (1978).
Raso, V. et al., Proc. Amer. Assoc. Cancer Research, vol. 20, p. 207 (1979).
Raso, V. et al., J. of Immunology, vol. 125, No. 6, pp. 2610-2616 (12-80).
Raso, V. et al., Cancer Research, vol. 41, pp. 2073-2078.
Nisonoff, A. et al., Arch. Biochem. Biophys., vol. 89, pp. 230-244 (1960).
Nisonoff, A. et al., Arch. Biochem. Biophys., vol. 93, No. 1, pp. 460-462 (1961).
Nisonoff, A., Current Contents, vol. 44, p. 25 (11-81).
Nisonoff, A. et al., Science, vol. 14, pp. 376-378 (1962).
Hood, L. E. et al., Immunology, Benjamin/Cummings Publishing Co. Inc., Menlo Park, CA, 1978; pp. 211-213.
Moskowitz M.
Padgett Benjamin R.
The University of Texas System Cancer Center
LandOfFree
Recombinant monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-527161